Wyss Geneva Spin-Off Clee Medical Secures Seed Financing to Bring Real-Time Vision to Brain Surgery

Contributed by: Business Wire

Logo

Tags

Health Technology

Technology

Finance

Radiology

Surgery

Business

Apps/Applications

Professional Services

Medical Devices

Neurology

Clinical Trials

Biotechnology

Science

Software

Research

Health

Seed Financing

More Like This

Craig Cook appointed Chief Business Officer and Co-founder at ABILITY Neurotech, the Wyss Geneva’s flagship spin-off

Wyss Center for Bio and Neuroengineering Announces Venture with dEEGtal Insight: An Innovative Tool for Early Epilepsy Detection

Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology

Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration

PR Newswire associated0

Esaote enters the field of neurosurgery by presenting an innovative intraoperative MRI system. I-Genius is the result of Esaote's research and collaboration with neurosurgeons.

Dr. Tracy Laabs, incoming Director, Wyss Center Geneva

Wyss Geneva Steps Into Its Next Chapter

WCS: wise cortical strip

WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor

Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization